Trials / Unknown
UnknownNCT02083874
Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- Sponsor
- The University of New South Wales · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Single subject repeated measures design of an open label administration of Cannabidiol (CBD) to 5 participants withdrawing from cannabis use in an inpatient setting. 300mg of CBD will be administered once on day 1, twice on days 2-5 and once on day 6. Participants will be discharged on day 7. CBD will be administered orally in capsules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CBD |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-09-01
- Completion
- 2014-12-01
- First posted
- 2014-03-11
- Last updated
- 2014-03-11
Source: ClinicalTrials.gov record NCT02083874. Inclusion in this directory is not an endorsement.